期刊文献+

莫西沙星的合成 被引量:26

Synthesis of Moxifloxacin
在线阅读 下载PDF
导出
摘要 以吡啶-2,3-二羧酸为原料,依次经脱水、氨解、环合、还原吡啶环及羰基、拆分和氢解脱苄基得(S,S)-八氢-6H-吡咯并[3,4-b]吡啶后,与1-环丙基-6,7-二氟-1,4-二氢-8-甲氧基-4-氧代喹啉-3-羧酸根-硼-二乙酸酐缩合并水解去螯合得到莫西沙星。总收率43.3%。 Moxifloxacin was synthesized from pyridine-2,3-dicarboxylic acid via dehydration, benzylamination,cyclization, reduction of pyridine ring and carbonyl groups, resolution and debenzylation to afford (S,S)-octahydro-6H-pyrrolo[3,4-b]pyridine which condensed with the boric chelate of the quinolone intermediate and then hydrolysis with anoverall yield of 43.3%.
机构地区 中国医学科学院
出处 《中国医药工业杂志》 CAS CSCD 北大核心 2004年第3期129-131,共3页 Chinese Journal of Pharmaceuticals
关键词 莫西沙星 合成 氟喹诺酮 抗菌剂 moxifloxacin fluoroquinolone antibacterial agent synthesis
  • 相关文献

参考文献1

二级参考文献25

  • 1[18]Stass HH, Muller F, Hundt HK, et al. Study of the influence of once-daily 400 mg moxifloxacin on pharmacokinetics and pharmacodynamics of warfarin in healthy volunteers. [C]. 38(th) Intersci Conf Antimicrob Agents Chemother, Sept 24-2 7, San Diego, 1998, Abst A13
  • 2[19]Stass HH, Kubitza D, Schwietert H, et al. Bay12-8039 does not interact with t heophylline. [C]. 20(th) Int Cong Chemother, June 29-July 3, Sydney, 1997, Abst3 356
  • 3[20]Krasemann C, Meyer JM, Springsklee M. Moxifloxacin (MFX) in community-acquired pneumonia (CAP)-A bacteriologic and clinical meta-analysis. [J]. Clin Microbiol Infect, 1999,5(Suppl 3): Abst 205
  • 4[21]Petipretz P. Moxifloxacin(MFX) versus amoxycillin(AMOX) in the treatment of community -acqnired suspected pneumococcal pneumonia: A mutinational double -blind randonized study. [J]. Clin Microbiol Infect, 1999,5(Suppl 3):Abst 207
  • 5[22]Wilson R,Kubin R,Ballin I, et al. Five day moxifloxacin therapy compared with 7 day clarithromycin therapy for the treatment of acute cxacerbations of chronic bronchitis. [J]. J Antimicrob Chemother, 1999,44(4): 501
  • 6[23]Krasemann C, Meyer JM, Springsklee M. Moxifloxacin(MFX) in acute sinusiti s (A S) - A bacteriologic and clinical meta-analysis. [J]. Clin Microbiol Infect, 1999,5(Suppl 3):Abst P204
  • 7[24]Leal del Rosal P. Efficacy and safety of moxifloxacin vs cephalexin in the treatment of mild to moderate uncomplicated skin and soft tissue infections (USS SI). [J]. J Antimicrob Chemother, 1999,44(Suppl A): Abst 493
  • 8[1]Hoogkamp-Korstanje JAA, Roelofs - Willemse J. Comparative in vitro activity of moxifloxacin against Gram - positive clinical isolates. [J]. J Antimicrob Chemother, 2000,45(1):31
  • 9[2]Blondeau JM. A review of the comparative in - vitro activities of 12 antimicrobial agents, with a focus on five new " respiratory qninolones". [J]. J Antimicrob Chemother, 1999,43 (SupplB): 1
  • 10[3]Boswell FJ, Andrews JM, Wise R, et al. Bactericidal properties of moxifloxacinand post-antibiotic effect. [J]. J Antimicrob Chemother, 1999,43(Suppl B):43

共引文献46

同被引文献201

引证文献26

二级引证文献69

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部